Skip to main content
SpringerLink
Log in

High-dose dapagliflozin increases risk of UTI

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Risk of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Treated with Dapagliflozin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Clinical Drug Investigation 43: 209-225, et al. Apr 2023. Available from: URL: https://doi.org/10.1007/s40261-023-01256-9

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

High-dose dapagliflozin increases risk of UTI. Reactions Weekly 1953, 6 (2023). https://doi.org/10.1007/s40278-023-37441-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-37441-6

Search

Navigation